Cochrane Abstracts
Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risk‐reducing Bilateral Salpingo‐oophorectomy in Women With BRCA1 or BRCA2 Mutations." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436031/all/Risk‐reducing_bilateral_salpingo‐oophorectomy_in_women_with_BRCA1_or_BRCA2_mutations.
Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436031/all/Risk‐reducing_bilateral_salpingo‐oophorectomy_in_women_with_BRCA1_or_BRCA2_mutations. Accessed December 6, 2024.
Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436031/all/Risk‐reducing_bilateral_salpingo‐oophorectomy_in_women_with_BRCA1_or_BRCA2_mutations
Risk‐reducing Bilateral Salpingo‐oophorectomy in Women With BRCA1 or BRCA2 Mutations [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436031/all/Risk‐reducing_bilateral_salpingo‐oophorectomy_in_women_with_BRCA1_or_BRCA2_mutations.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations
ID - 436031
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436031/all/Risk‐reducing_bilateral_salpingo‐oophorectomy_in_women_with_BRCA1_or_BRCA2_mutations
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
